These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 5778021)

  • 21. Monosodium glutamate: specific brain lesion questioned.
    Lowe CU; Zavon MR; Olney JW; Sharpe LG
    Science; 1970 Feb; 167(3920):1016-7. PubMed ID: 4983437
    [No Abstract]   [Full Text] [Related]  

  • 22. Oral and subcutaneous administration of monosodium glutamate to infant rodents and dogs.
    Oser BL; Carson S; Vogin EE; Cox GE
    Nature; 1971 Feb; 229(5284):411-3. PubMed ID: 4926993
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of gold-thioglucose and monosodium glutamate to induce obesity in mice.
    Djazayery A; Miller DS
    Proc Nutr Soc; 1973 May; 32(1):30A-31A. PubMed ID: 4586579
    [No Abstract]   [Full Text] [Related]  

  • 24. Cross-fostering reduces obesity induced by early exposure to monosodium glutamate in male rats.
    Miranda RA; da Silva Franco CC; de Oliveira JC; Barella LF; Tófolo LP; Ribeiro TA; Pavanello A; da Conceição EP; Torrezan R; Armitage J; Lisboa PC; de Moura EG; de Freitas Mathias PC; Vieira E
    Endocrine; 2017 Jan; 55(1):101-112. PubMed ID: 27116693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcutaneous administration of monosodium glutamate to pregnant mice reduces weight gain in pups during lactation.
    Park JH; Choi TS
    Lab Anim; 2016 Apr; 50(2):94-9. PubMed ID: 26043886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brown adipose tissue thermogenesis, torpor, and obesity of glutamate-treated mice.
    Tokuyama K; Himms-Hagen J
    Am J Physiol; 1986 Oct; 251(4 Pt 1):E407-15. PubMed ID: 2876642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine.
    Olney JW; Ho OL
    Nature; 1970 Aug; 227(5258):609-11. PubMed ID: 5464249
    [No Abstract]   [Full Text] [Related]  

  • 28. Glutamate-induced brain damage in infant primates.
    Olney JW; Sharpe LG; Feigin RD
    J Neuropathol Exp Neurol; 1972 Jul; 31(3):464-88. PubMed ID: 4626680
    [No Abstract]   [Full Text] [Related]  

  • 29. Glutamate-type hypothalamic-pituitary syndrome in mice treated with aspartate or cysteate in infancy.
    Schainker B; Olney JW
    J Neural Transm; 1974; 35(3):207-15. PubMed ID: 4427110
    [No Abstract]   [Full Text] [Related]  

  • 30. Obesity, voracity, and short stature: the impact of glutamate on the regulation of appetite.
    Hermanussen M; García AP; Sunder M; Voigt M; Salazar V; Tresguerres JA
    Eur J Clin Nutr; 2006 Jan; 60(1):25-31. PubMed ID: 16132059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of chronic methylphenidate treatment on growth and endocrine function in the developing rat.
    Greeley GH; Kizer JS
    J Pharmacol Exp Ther; 1980 Dec; 215(3):545-51. PubMed ID: 7003098
    [No Abstract]   [Full Text] [Related]  

  • 32. Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice.
    Tsuneyama K; Nishida T; Baba H; Taira S; Fujimoto M; Nomoto K; Hayashi S; Miwa S; Nakajima T; Sutoh M; Oda E; Hokao R; Imura J
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1736-43. PubMed ID: 24730643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain damage in the male domestic fowl treated with monosodium glutamate.
    Snapir N; Robinzon B; Perek M
    Poult Sci; 1971 Sep; 50(5):1511-4. PubMed ID: 5094398
    [No Abstract]   [Full Text] [Related]  

  • 34. Models of neuroendocrine regulation: use of monosodium glutamate as an investigational tool.
    Nemeroff CB; Lipton MA; Kizer JS
    Dev Neurosci; 1978; 1(2):102-9. PubMed ID: 39735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspartate-induced neuronal necrosis in infant mice: protective effect of carbohydrate and insulin.
    Finkelstein MW; Daabees TT; Stegink LD; Applebaum AE
    J Toxicol Environ Health; 1988; 23(3):395-406. PubMed ID: 3280815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BDNF levels in adipose tissue and hypothalamus were reduced in mice with MSG-induced obesity.
    Jin YJ; Cao PJ; Bian WH; Li ME; Zhou R; Zhang LY; Yang MZ
    Nutr Neurosci; 2015; 18(8):376-82. PubMed ID: 26230366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tracking glutamate lesions in the neonatal brain.
    Cooper P
    Food Cosmet Toxicol; 1979 Feb; 17(1):83-4. PubMed ID: 437615
    [No Abstract]   [Full Text] [Related]  

  • 38. Monosodium glutamate: absence of hypothalamic lesions after ingestion by newborn primates.
    Reynolds WA; Lemkey-Johnston N; Filer LJ; Pitkin RM
    Science; 1971 Jun; 172(3990):1342-4. PubMed ID: 4996307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity induced by monosodium glutamate in mice.
    Matsuyama S; Oki Y; Yokoki Y
    Natl Inst Anim Health Q (Tokyo); 1973; 13(2):91-101. PubMed ID: 4792405
    [No Abstract]   [Full Text] [Related]  

  • 40. The Monosodium L-glutamate (MSG) syndrome in mice develops independently of housing condition.
    Barnhart JE; Pizzi WJ
    Neurobehav Toxicol Teratol; 1982; 4(5):549-56. PubMed ID: 7177307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.